Drug class
Prokinetic substituted-benzamide; 5-HT receptor agonist and dopamine D2 antagonist
Mechanism of action
Acts as a 5-HT4 agonist and dopamine D2 antagonist; stimulation of enteric 5-HT4 receptors enhances acetylcholine release and gastrointestinal motility. Published pharmacology also describes 5-HT1 agonist and 5-HT2 antagonist activity.
General use cases
- Functional dyspepsia, particularly postprandial-distress or dysmotility-predominant symptoms, in jurisdictions where cinitapride is authorised
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
